These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Placenta and myometrium--the two main sources of fibrinolytic components during pregnancy. Uszyński M, Maciejewski K, Uszyński W, Kuczyński J. Gynecol Obstet Invest; 2001; 52(3):189-93. PubMed ID: 11598362 [Abstract] [Full Text] [Related]
24. Are the maternal and umbilical VEGF-A and SVEGF-R1 altered in pregnancies complicated by preeclampsia with or without intrauterine foetal growth retardation? Preliminary communication. Laskowska M, Laskowska K, Leszczyńska-Gorzelak B, Oleszczuk J. Med Wieku Rozwoj; 2008; 12(1):499-506. PubMed ID: 18663270 [Abstract] [Full Text] [Related]
29. Fibrinolytic system and reproductive process with special reference to fibrinolytic failure in pre-eclampsia. Gilabert J, Estellés A, Grancha S, España F, Aznar J. Hum Reprod; 1995 Dec; 10 Suppl 2():121-31. PubMed ID: 8745310 [Abstract] [Full Text] [Related]
37. Relationship between plasma levels of components of the fibrinolytic system and acute-phase reactants in patients with uterine malignancies. Kirchheimer JC, Kölbl H, Tatra G, Binder BR. Eur J Clin Invest; 1990 Feb; 20(1):79-84. PubMed ID: 1690655 [Abstract] [Full Text] [Related]